The global respiratory disposable market size is calculated at USD 3.15 billion in 2025 and is forecasted to reach around USD 7.18 billion by 2034, accelerating at a CAGR of 9.60% from 2025 to 2034. The North America respiratory disposable market size surpassed USD 1.23 billion in 2024 and is expanding at a CAGR of 9.65% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Respiratory Disposable Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Respiratory Disposable Market, by Product
8.1.1. Laryngoscope
8.1.1.1. Market Revenue and Forecast
8.1.2. Tubes
8.1.2.1. Market Revenue and Forecast
8.1.3. Breathing Bag
8.1.3.1. Market Revenue and Forecast
8.1.4. Masks
8.1.4.1. Market Revenue and Forecast
8.1.5. Resuscitator
8.1.5.1. Market Revenue and Forecast
8.1.6. Others
8.1.6.1. Market Revenue and Forecast
9.1. Respiratory Disposable Market, by Patient Group e
9.1.1. Neonatal & Pediatric
9.1.1.1. Market Revenue and Forecast
9.1.2. Adult
9.1.2.1. Market Revenue and Forecast
9.1.3. Geriatric
9.1.3.1. Market Revenue and Forecast
10.1. Respiratory Disposable Market, by End User
10.1.1. Hospitals, Nursing Homes, & Clinics
10.1.1.1. Market Revenue and Forecast
10.1.2. Trauma Centers
10.1.2.1. Market Revenue and Forecast
10.1.3. Homecare
10.1.3.1. Market Revenue and Forecast
11.1. Respiratory Disposable Market, by Application
11.1.1. Pharmaceuticals
11.1.1.1. Market Revenue and Forecast
11.1.2. Pharmaceuticals
11.1.2.1. Market Revenue and Forecast
11.1.3. Cosmetics
11.1.3.1. Market Revenue and Forecast
11.1.4. Automobiles
11.1.4.1. Market Revenue and Forecast
11.1.5. Metals
11.1.5.1. Market Revenue and Forecast
11.1.6. Chemical Companies
11.1.6.1. Market Revenue and Forecast
11.1.7. Health Sectors
11.1.7.1. Market Revenue and Forecast
11.1.8. Power generation
11.1.8.1. Market Revenue and Forecast
11.1.9. Oil and gases and other
11.1.9.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product
12.1.2. Market Revenue and Forecast, by Patient Group
12.1.3. Market Revenue and Forecast, by End User
12.1.4. Market Revenue and Forecast, by Application
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product
12.1.5.2. Market Revenue and Forecast, by Patient Group
12.1.5.3. Market Revenue and Forecast, by End User
12.1.5.4. Market Revenue and Forecast, by Application
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product
12.1.6.2. Market Revenue and Forecast, by Patient Group
12.1.6.3. Market Revenue and Forecast, by End User
12.1.6.4. Market Revenue and Forecast, by Application
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product
12.2.2. Market Revenue and Forecast, by Patient Group
12.2.3. Market Revenue and Forecast, by End User
12.2.4. Market Revenue and Forecast, by Application
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product
12.2.5.2. Market Revenue and Forecast, by Patient Group
12.2.5.3. Market Revenue and Forecast, by End User
12.2.5.4. Market Revenue and Forecast, by Application
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product
12.2.6.2. Market Revenue and Forecast, by Patient Group
12.2.6.3. Market Revenue and Forecast, by End User
12.2.6.4. Market Revenue and Forecast, by Application
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product
12.2.7.2. Market Revenue and Forecast, by Patient Group
12.2.7.3. Market Revenue and Forecast, by End User
12.2.7.4. Market Revenue and Forecast, by Application
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product
12.2.8.2. Market Revenue and Forecast, by Patient Group
12.2.8.3. Market Revenue and Forecast, by End User
12.2.8.4. Market Revenue and Forecast, by Application
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product
12.3.2. Market Revenue and Forecast, by Patient Group
12.3.3. Market Revenue and Forecast, by End User
12.3.4. Market Revenue and Forecast, by Application
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product
12.3.5.2. Market Revenue and Forecast, by Patient Group
12.3.5.3. Market Revenue and Forecast, by End User
12.3.5.4. Market Revenue and Forecast, by Application
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product
12.3.6.2. Market Revenue and Forecast, by Patient Group
12.3.6.3. Market Revenue and Forecast, by End User
12.3.6.4. Market Revenue and Forecast, by Application
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product
12.3.7.2. Market Revenue and Forecast, by Patient Group
12.3.7.3. Market Revenue and Forecast, by End User
12.3.7.4. Market Revenue and Forecast, by Application
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product
12.3.8.2. Market Revenue and Forecast, by Patient Group
12.3.8.3. Market Revenue and Forecast, by End User
12.3.8.4. Market Revenue and Forecast, by Application
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product
12.4.2. Market Revenue and Forecast, by Patient Group
12.4.3. Market Revenue and Forecast, by End User
12.4.4. Market Revenue and Forecast, by Application
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product
12.4.5.2. Market Revenue and Forecast, by Patient Group
12.4.5.3. Market Revenue and Forecast, by End User
12.4.5.4. Market Revenue and Forecast, by Application
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product
12.4.6.2. Market Revenue and Forecast, by Patient Group
12.4.6.3. Market Revenue and Forecast, by End User
12.4.6.4. Market Revenue and Forecast, by Application
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product
12.4.7.2. Market Revenue and Forecast, by Patient Group
12.4.7.3. Market Revenue and Forecast, by End User
12.4.7.4. Market Revenue and Forecast, by Application
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product
12.4.8.2. Market Revenue and Forecast, by Patient Group
12.4.8.3. Market Revenue and Forecast, by End User
12.4.8.4. Market Revenue and Forecast, by Application
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product
12.5.2. Market Revenue and Forecast, by Patient Group
12.5.3. Market Revenue and Forecast, by End User
12.5.4. Market Revenue and Forecast, by Application
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product
12.5.5.2. Market Revenue and Forecast, by Patient Group
12.5.5.3. Market Revenue and Forecast, by End User
12.5.5.4. Market Revenue and Forecast, by Application
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product
12.5.6.2. Market Revenue and Forecast, by Patient Group
12.5.6.3. Market Revenue and Forecast, by End User
12.5.6.4. Market Revenue and Forecast, by Application
13.1. Fisher and Paykel Healthcare
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Smith Group (Smith Medical Inc.)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Hamilton Medical AG
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Getinge AB
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Invacare Corporation
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Masimo Corporation
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Medtronic Plc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Dragerwerk AG and CO. KGAA
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Air liquid S.A
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Chart Industries
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample